PRAXPraxis Precision Medicines,...

Nasdaq praxismedicines.com


$ 41.49 $ 1.60 (4.02 %)    

Friday, 28-Jun-2024 15:59:53 EDT
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 41.36
$ 40.04
$ 0.00 x 0
$ 41.64 x 200
$ 39.48 - $ 42.27
$ 12.75 - $ 67.21
3,296,469
na
575.08M
$ -0.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-05-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 02-07-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-17-2021 12-31-2020 10-K
15 11-23-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 value-of-praxis-precision-medicines-lead-program-in-essential-tremor-alone-is-underappreciated-analyst

Needham rates Praxis Precision Medicines Buy with a $145 target. Key programs include ulixacaltamide for essential tremor (Phas...

 needham-initiates-coverage-on-praxis-precision-medicine-with-buy-rating-announces-price-target-of-145

Needham analyst Ami Fadia initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announces Pric...

 guggenheim-initiates-coverage-on-praxis-precision-medicine-with-buy-rating-announces-price-target-of-155

Guggenheim analyst Yatin Suneja initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announce...

 truist-securities-maintains-buy-on-praxis-precision-medicine-maintains-150-price-target

Truist Securities analyst Joon Lee maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $150 price tar...

 hc-wainwright--co-reiterates-buy-on-praxis-precision-medicine-maintains-105-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $10...

 praxis-precision-medicines-advances-precision-therapies-for-cns-disorders-anticipates-key-milestones-in-seizure-and-pediatric-epilepsy-treatment

 Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into t...

 baird-initiates-coverage-on-praxis-precision-medicine-with-outperform-rating-announces-price-target-of-117

Baird analyst Joel Beatty initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform rating and announc...

 hc-wainwright--co-reiterates-buy-on-praxis-precision-medicine-maintains-105-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $10...

 praxis-precision-medicines-priced-200m-offering-of-33m-shares-at-5650share

Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into th...

 why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

 jefferies-maintains-buy-on-praxis-precision-medicine-raises-price-target-to-128

Jefferies analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from...

 why-praxis-precision-medicines-stock-is-trading-higher-tuesday

Praxis Precision Medicines updates Phase 2a study on PRAX-628 in epilepsy patients with photo paroxysmal response, indicating p...